These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 9857087

  • 1. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
    Tourwé D, Mannekens E, Diem TN, Verheyden P, Jaspers H, Tóth G, Péter A, Kertész I, Török G, Chung NN, Schiller PW.
    J Med Chem; 1998 Dec 17; 41(26):5167-76. PubMed ID: 9857087
    [Abstract] [Full Text] [Related]

  • 2. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
    Tóth G, Ioja E, Tömböly C, Ballet S, Tourwé D, Péter A, Martinek T, Chung NN, Schiller PW, Benyhe S, Borsodi A.
    J Med Chem; 2007 Jan 25; 50(2):328-33. PubMed ID: 17228874
    [Abstract] [Full Text] [Related]

  • 3. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S, Balboni G, Guerrini R, Tomatis R, Bianchi C, Bryant SD, Cooper PS, Lazarus LH.
    J Med Chem; 1997 Sep 12; 40(19):3100-8. PubMed ID: 9301674
    [Abstract] [Full Text] [Related]

  • 4. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E, Tourwé D, Kertész I, Tóth G, Borsodi A, Benyhe S.
    Brain Res Bull; 2007 Sep 14; 74(1-3):119-29. PubMed ID: 17683797
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R, Wilkes BC, Chung NN, Lemieux C, Schiller PW.
    Int J Pept Protein Res; 1996 Nov 14; 48(5):411-9. PubMed ID: 8956074
    [Abstract] [Full Text] [Related]

  • 9. The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.
    Schiller PW, Weltrowska G, Berezowska I, Nguyen TM, Wilkes BC, Lemieux C, Chung NN.
    Biopolymers; 1999 Nov 14; 51(6):411-25. PubMed ID: 10797230
    [Abstract] [Full Text] [Related]

  • 10. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
    Wilkes BC, Schiller PW.
    Biopolymers; 1995 Nov 14; 37(6):391-400. PubMed ID: 8589244
    [Abstract] [Full Text] [Related]

  • 11. [Aladan3]TIPP: a fluorescent delta-opioid antagonist with high delta-receptor binding affinity and delta selectivity.
    Chen H, Chung NN, Lemieux C, Zelent B, Vanderkooi JM, Gryczynski I, Wilkes BC, Schiller PW.
    Biopolymers; 2005 Nov 14; 80(2-3):325-31. PubMed ID: 15614807
    [Abstract] [Full Text] [Related]

  • 12. Opioid receptor binding characteristics and structure-activity studies of novel tetrapeptides in the TIPP (Tyr-Tic-Phe-Phe) series.
    Ioja E, Tóth G, Benyhe S, Tourwe D, Péter A, Tömböly C, Borsodi A.
    Neurosignals; 2005 Nov 14; 14(6):317-28. PubMed ID: 16772734
    [Abstract] [Full Text] [Related]

  • 13. (2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.
    Hosohata K, Varga EV, Alfaro-Lopez J, Tang X, Vanderah TW, Porreca F, Hruby VJ, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 2003 Feb 14; 304(2):683-8. PubMed ID: 12538822
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S, Johnson CA, Carter RL, Clayton SD, Rice KC, Xu H, Davis P, Porreca F, Rothman RB.
    J Med Chem; 1998 Jul 16; 41(15):2872-81. PubMed ID: 9667975
    [Abstract] [Full Text] [Related]

  • 15. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.
    Salvadori S, Attila M, Balboni G, Bianchi C, Bryant SD, Crescenzi O, Guerrini R, Picone D, Tancredi T, Temussi PA.
    Mol Med; 1995 Sep 16; 1(6):678-89. PubMed ID: 8529134
    [Abstract] [Full Text] [Related]

  • 16. Highly selective fluorescent analogue of the potent delta-opioid receptor antagonist Dmt-Tic.
    Balboni G, Salvadori S, Dal Piaz A, Bortolotti F, Argazzi R, Negri L, Lattanzi R, Bryant SD, Jinsmaa Y, Lazarus LH.
    J Med Chem; 2004 Dec 16; 47(26):6541-6. PubMed ID: 15588089
    [Abstract] [Full Text] [Related]

  • 17. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S, Khare NK, Saini SK, Seitz LE, Bartlett JL, Davis P, Dersch CM, Porreca F, Rothman RB, Bilsky EJ.
    J Med Chem; 2004 Mar 11; 47(6):1400-12. PubMed ID: 14998329
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A novel cyclic enkephalin analogue with potent opioid antagonist activity.
    Weltrowska G, Lu Y, Lemieux C, Chung NN, Schiller PW.
    Bioorg Med Chem Lett; 2004 Sep 20; 14(18):4731-3. PubMed ID: 15324897
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.